Clinical trial

Appropriate Timing of HAART in Co-infected HIV/TB Patients

NCT01014481

Study summary

ClinicalTrials.gov

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention tenofovir, lamivudine, efavirenz Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-10-01

PhasePHASE4

Conditions

HIV Infectionsunresolved

Tuberculosisverified · MONDO: tuberculosis

Interventions

tenofovir, lamivudine, efavirenzDRUG

Sponsors & collaborators

Bamrasnaradura Infectious Diseases Institutelead sponsor

Mahidol Universitycollaborator

Thai Red Cross AIDS Research Centrecollaborator

Mapped research locations

NonthaburiChangwat Nonthaburi, Thailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01014481 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.